Question 1

Has Asisat Ope received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,182,639 in general payments to Asisat Ope across 372 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Asisat Ope did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Asisat Ope come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Modernatx, Inc.	103	$1,596,277
Seqirus USA Inc	134	$340,586
Orasure Technologies Inc.	7	$127,231
GSK	47	$111,758
Pfizer	19	$5,763
Novo Nordisk	13	$198
AbbVie(2 entities)	7	$142
Merck	6	$83
Antares Pharma, Inc.	3	$53
Amarin Pharma, Inc.	3	$51
Sanofi-aventis U.S. LLC	3	$49
Amgen	3	$46
AstraZeneca	3	$46
Johnson & Johnson	3	$45
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$43
Optinose US, Inc.	2	$42
Sanofi Pasteur Inc.	2	$37
Boehringer Ingelheim	2	$34
Takeda Pharmaceuticals U.S.A., Inc.	2	$29
Hologic Sales And Service, LLC	1	$23
Dynavax Technologies Corporation	1	$19
IBSA Pharma Inc.	1	$18
Genentech USA, Inc.	1	$17
Biohaven Pharmaceuticals, Inc.	1	$17
Shire North American Group Inc	1	$15
Eisai Inc.	1	$15

Asisat Ope

Payments from drug & device makers

Who reported the general payments

How this compares

Other family medicine in Sugar Land